BeiGene and Boehringer Ingelheim Announce Commercial Supply Agreement for Anti-PD-1 Antibody Tislelizumab Jan 9, 2018 Life Science
China News Weekly 44 – Zhejiang DTRM Completes $60 Million A Round for US-China Clinical Trials Jan 9, 2018 Life Science, Technology
Genostics Invests $13.5 Million in UK’s Oncimmune for China Rights to Lung Cancer Test Jan 4, 2018 Life Science
Life Science & Technology Weekly 126 – Big tech’s spending on healthcare equity deals up 875% in 5 years: What 5 tech giants are up to Jan 4, 2018 Life Science, Technology
CStone’s Anti-CTLA-4 Antibody CS1002 Filed for Clinical Trial Approval in Australia Dec 29, 2017 Life Science
